GlassScriptPhysician profile
Michael T Rozell
NPI 1962769653
$11,238.43
in general payments reported to CMS, 2019-2025
15 companies · $46.73 in 2025
The $46.73 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,361 · 2020: $2,671 · 2021: $477 · 2022: $146 · 2023: $2,487 · 2024: $1,049 · 2025: $46.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,678 · Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,677.80 |
| Food and Beverage | $905.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $3,395.65 | 2019-2020 | |
| Prodigy Surgical Distribution, INC. | $2,127.92 | 2019-2020 | |
| Stryker Corporation | $1,204.02 | 2021-2024 | Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $1,081.96 | 2019-2023 | |
| Exactech, INC. | $970.69 | 2019 | |
| Impactortho, INC. | $909.68 | 2021-2023 | |
| Skeletal Dynamics INC | $494.12 | 2023-2025 | Geminus, Ijs, Align |
| Smith+Nephew, INC. | $277.14 | 2019-2022 | |
| Medtronic USA, INC. | $230.08 | 2020 | |
| Zimmer Biomet Holdings, INC. | $221.16 | 2021-2025 | Comprehensive |
| Encore Medical, LP | $95.57 | 2023 | Djo Surgical |
| Celgene Corporation | $82.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $67.27 | 2019 | |
| Rigel Pharmaceuticals, INC. | $65.24 | 2021 | |
| Abbvie INC. | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rozell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.